Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report
Henrik H Rossing, Morten Grauslund, Edyta M Urbanska, Linea C Melchior, Charlotte Rask, Junia C Costa, Birgit G Skov, Jens Benn Sørensen, Eric Santoni-Rugiu
Dive into the research topics of 'Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report'. Together they form a unique fingerprint.